ARMP

Stock ticker: ASE

PRICE

CHANGE

CAPITALIZATION

Armata Pharmaceuticals (ARMP) Ownership - Who owns Armata Pharmaceuticals?

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

5005 McConnell Avenue

Phone

+1 310 665-2928

Employees

Web

https://www.armatapharma.com

Details

Group

Domestic Stock Funds

Fundamentals

ARMP

Capitalization

71.8M

P/E Ratio

N/A

Risk (Beta)

1.64

Dividend Yield

N/A

Total Cash

17.1M

Total Cash/Share

0.47

Total Debt

140M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

-50.97M

P/B Ratio

N/A

Cash Flow

N/A

Earnings

-1.15

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

362K

Current Ratio

0.19

Current Revenue Per Employee

815.79

Dividends Per Share - Security

N/A

EBITDA

-31.21M

Float

N/A

Float - Current

N/A

Gross Income Margin

100.00

Revenue To Assets

-39.21

Shares Held By Institutions

3.84M

Shares Outstanding - Current

36.2M

Total Liabilities

149M

Total Volume MTD

N/A

Value

-1

Gain YTD

7.314

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of novel bacteriophage-based therapeutics

Industry Biotechnology